Department of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts.
Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e943-e956. doi: 10.1210/clinem/dgaa799.
Little is known about the specific breastmilk components responsible for protective effects on infant obesity. Whether 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME), an oxidized linoleic acid metabolite and activator of brown fat metabolism, is present in human milk, or linked to infant adiposity, is unknown.
To examine associations between concentrations of 12,13-diHOME in human milk and infant adiposity.
Prospective cohort study from 2015 to 2019, following participants from birth to 6 months of age.
Academic medical centers.
Volunteer sample of 58 exclusively breastfeeding mother-infant pairs; exclusion criteria included smoking, gestational diabetes, and health conditions with the potential to influence maternal or infant weight gain.
Infant anthropometric measures including weight, length, body mass index (BMI), and body composition at birth and at 1, 3, and 6 months postpartum.
We report for the first time that 12,13-diHOME is present in human milk. Higher milk 12,13-diHOME level was associated with increased weight-for-length Z-score at birth (β = 0.5742, P = 0.0008), lower infant fat mass at 1 month (P = 0.021), and reduced gain in BMI Z-score from 0 to 6 months (β = -0.3997, P = 0.025). We observed similar associations between infant adiposity and milk abundance of related oxidized linoleic acid metabolites 12,13-Epoxy-9(Z)-octadecenoic acid (12,13-epOME) and 9,10-Dihydroxy-12-octadecenoic acid (9,10-diHOME), and metabolites linked to thermogenesis including succinate and lyso-phosphatidylglycerol 18:0. Milk abundance of 12,13-diHOME was not associated with maternal BMI, but was positively associated with maternal height, milk glucose concentration, and was significantly increased after a bout of moderate exercise.
We report novel associations between milk abundance of 12,13-diHOME and adiposity during infancy.
对于导致婴儿肥胖的保护性的母乳成分知之甚少。12,13-二羟基-9Z-十八碳烯酸(12,13-二 H OME),一种氧化亚油酸代谢物和褐色脂肪代谢的激活剂,是否存在于人乳中,或与婴儿肥胖有关,尚不清楚。
检查人乳中 12,13-二 H OME 浓度与婴儿肥胖的相关性。
2015 年至 2019 年的前瞻性队列研究,从出生到 6 个月的时间内对参与者进行随访。
学术医疗中心。
58 名纯母乳喂养的母婴对志愿者样本;排除标准包括吸烟、妊娠糖尿病和可能影响母婴体重增加的健康状况。
包括出生时和产后 1、3 和 6 个月时的婴儿体重、身长、体重指数(BMI)和身体成分的婴儿人体测量指标。
我们首次报告 12,13-二 H OME 存在于人乳中。较高的乳汁 12,13-二 H OME 水平与出生时体重长度 Z 评分增加(β=0.5742,P=0.0008)、1 个月时婴儿脂肪量减少(P=0.021)以及 0 至 6 个月时 BMI Z 评分增加减少(β=-0.3997,P=0.025)相关。我们在婴儿肥胖与相关氧化亚油酸代谢物 12,13-环氧-9(Z)-十八碳烯酸(12,13-epOME)和 9,10-二羟基-12-十八碳烯酸(9,10-二 H OME)以及与产热有关的代谢物如琥珀酸和溶血磷脂酰甘油 18:0 的乳汁丰度之间观察到类似的关联,12,13-二 H OME 的乳汁丰度与母体 BMI 无关,但与母体身高、乳汁葡萄糖浓度呈正相关,且在剧烈运动后显著增加。
我们报告了 12,13-二 H OME 乳汁丰度与婴儿期肥胖之间的新关联。